A novel targeted delivery system utilizing a cephalosporin-oncolytic prodrug activated by an antibody β-lactamase conjugate for the treatment of cancer

Timothy A. Shepherd, Louis N. Jungheim, Damon L. Meyer, James J. Starling

Bioorganic & Medicinal Chemistry Letters · 1991 · 56 citations · 15 references

Concepts

References

15